Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 101

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Gastroprotective Effects of Polyphenols against Various Gastro-Intestinal Disorders: A Mini-Review with Special Focus on Clinical Evidence

Chiu, Hui-Fang, Venkatakrishnan, Kamesh, Golovinskaia, Oksana, Wang, Chin-Kun·2021·Molecules
DOI 10.3390/molecules26072090
Open this paper in CoChat — free account

Abstract

Polyphenols are classified as an organic chemical with phenolic units that display an array of biological functions. However, polyphenols have very low bioavailability and stability, which make polyphenols a less bioactive compound. Many researchers have indicated that several factors might affect the efficiency and the metabolism (biotransformation) of various polyphenols, which include the gut microbiota, structure, and physical properties as well as its interactions with other dietary nutrients (macromolecules). Hence, this mini-review covers the two-way interaction between polyphenols and gut microbiota (interplay) and how polyphenols are metabolized (biotransformation) to produce various polyphenolic metabolites. Moreover, the protective effects of numerous polyphenols and their metabolites against various gastrointestinal disorders/diseases including gastritis, gastric cancer, colorectal cancer, inflammatory bowel disease (IBD) like ulcerative colitis (UC), Crohn’s disease (CD), and irritable bowel syndrome (IBS) like celiac disease (CED) are discussed. For this review, the authors chose only a few popular polyphenols (green tea polyphenol, curcumin, resveratrol, quercetin), and a discussion of their proposed mechanism underpinning the gastroprotection was elaborated with a special focus on clinical evidence. Overall, this contribution would help the general population and science community to identify a potent polyphenol with strong antioxidant, anti-inflammatory, anti-cancer, prebiotic, and immunomodulatory properties to combat various gut-related diseases or disorders (complementary therapy) along with modified lifestyle pattern and standard gastroprotective drugs. However, the data from clinical trials are much limited and hence many large-scale clinical trials should be performed (with different form/metabolites and dose) to confirm the gastroprotective activity of the above-mentioned polyphenols and their metabolites before recommendation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules26072090

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 115

  1. Filosa, 2018, Polyphenols-Gut Microbiota Interplay and Brain Neuromodulation, Neural Regen. Res., 13, 2055, 10.4103/1673-5374.241429 · DOI
  2. Rasouli, 2017, Polyphenols and their benefits: A review, Int. J. Food Prop., 20, 1700
  3. Adebooye, O.C., Alashi, A.M., and Aluko, R.E. (2018). A Brief Review on Emerging Trends in Global Polyphenol Research. J. Food Biochem., e12519. · DOI
  4. Bohn, 2014, Dietary Factors Affecting Polyphenol Bioavailability, Nutr. Rev., 72, 429, 10.1111/nure.12114 · DOI
  5. Cueva, 2017, An Integrated View of the Effects of Wine Polyphenols and Their Relevant Metabolites on Gut and Host Health, Molecules, 22, 99, 10.3390/molecules22010099 · DOI
  6. Chiu, H.F., Fang, C.Y., Shen, Y.C., Venkatakrishnan, K., and Wang, C.K. (2021). Efficacy of Probiotic Milk Formula on Blood Lipid and Intestinal Function in Mild Hypercholesterolemic Volunteers: A Placebo-Control, Randomized Clinical Trial. Probiotics Antimicrob. Proteins, 1–9. · DOI
  7. Wan, 2021, Dietary Polyphenol Impact on Gut Health and Microbiota, Crit. Rev. Food Sci. Nutr., 61, 690, 10.1080/10408398.2020.1744512 · DOI · Paper page
  8. Catinean, 2018, An Overview on the Interplay between Nutraceuticals and Gut Microbiota, PeerJ, 6, e4465, 10.7717/peerj.4465 · DOI
  9. Louis, 2017, Formation of Propionate and Butyrate by the Human Colonic Microbiota, Environ. Microbiol., 19, 29, 10.1111/1462-2920.13589 · DOI · Paper page
  10. Moorthy, 2020, Prebiotic Potential of Polyphenols, Its Effect on Gut Microbiota and Anthropometric/Clinical Markers: A Systematic Review of Randomised Controlled Trials, Trends Food Sci. Technol., 99, 634, 10.1016/j.tifs.2020.03.036 · DOI
  11. Cabral, 2019, Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency, Nutrients, 11, 2216, 10.3390/nu11092216 · DOI
  12. Gupta, 2013, Biotransformation of Polyphenols for Improved Bioavailability and Processing Stability, Adv. Food Nutr. Res., 69, 183, 10.1016/B978-0-12-410540-9.00004-1 · DOI
  13. Roberts, 2015, Microbial Protection and Virulence in Periodontal Tissue as a Function of Polymicrobial Communities: Symbiosis and Dysbiosis, Periodontol. 2000, 69, 18, 10.1111/prd.12087 · DOI
  14. Kitamoto, 2016, Pathogenic Role of the Gut Microbiota in Gastrointestinal Diseases, Intest. Res., 14, 127, 10.5217/ir.2016.14.2.127 · DOI
  15. Kim, 2014, Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation, Immune Netw., 14, 277, 10.4110/in.2014.14.6.277 · DOI · Paper page
  16. Chiu, 2016, Improvement of Green Tea Polyphenol with Milk on Skin with Respect to Antioxidation in Healthy Adults: A Double-Blind Placebo-Controlled Randomized Crossover Clinical Trial, Food Funct., 7, 893, 10.1039/C5FO01271F · DOI
  17. Adami, G.R., Tangney, C., Schwartz, J.L., and Dang, K.C. (2020). Gut/Oral Bacteria Variability May Explain the High Efficacy of Green Tea in Rodent Tumor Inhibition and Its Absence in Humans. Molecules, 25. · DOI
  18. Lambert, 2007, Biotransformation of Green Tea Polyphenols and the Biological Activities of Those Metabolites, Mol. Pharm., 4, 819, 10.1021/mp700075m · DOI
  19. Yan, 2020, Antioxidant Mechanism of Tea Polyphenols and Its Impact on Health Benefits, Anim. Nutr., 6, 115, 10.1016/j.aninu.2020.01.001 · DOI · Paper page
  20. Afzal, 2015, Green Tea Polyphenols and Their Potential Role in Health and Disease, Inflammopharmacology, 23, 151, 10.1007/s10787-015-0236-1 · DOI
  21. Almatroodi, 2020, Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer, Molecules, 25, 3146, 10.3390/molecules25143146 · DOI · Paper page
  22. Yang, 2016, Inhibition of Green Tea Polyphenol EGCG ((−)-Epigallocatechin-3-Gallate) on the Proliferation of Gastric Cancer Cells by Suppressing Canonical Wnt/β-Catenin Signalling Pathway, Int. J. Food Sci. Nutr., 67, 818, 10.1080/09637486.2016.1198892 · DOI
  23. Du, 2012, Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea, Nutrients, 4, 1679, 10.3390/nu4111679 · DOI
  24. Kim, 2004, EGCG Blocks Tumor Promoter-Induced MMP-9 Expression via Suppression of MAPK and AP-1 Activation in Human Gastric AGS Cells, Anticancer Res., 24, 747
  25. Zhang, 2020, Integrated Transcriptomic and Metabolomic Analyses to Characterize the Anti-Cancer Effects of (−)-Epigallocatechin-3-Gallate in Human Colon Cancer Cells, Toxicol. Appl. Pharmacol., 401, 115100, 10.1016/j.taap.2020.115100 · DOI
  26. Negri, 2018, Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer, Nutrients, 10, 1936, 10.3390/nu10121936 · DOI
  27. Park, 2013, EGCG Inhibits Recepteur d’origine Nantais Expression by Suppressing Egr-1 in Gastric Cancer Cells, Int. J. Oncol., 42, 1120, 10.3892/ijo.2013.1775 · DOI
  28. Jiang, 2016, The Green Tea Polyphenol Epigallocatechin-3-Gallate Effectively Inhibits Helicobacter Pylori-Induced Gastritis in Mongolian Gerbils, Int. J. Clin. Exp. Med., 9, 2479
  29. Ruggiero, 2007, Red Wine and Green Tea Reduce H Pylori-or VacA-Induced Gastritis in a Mouse Model, World J. Gastroenterol. WJG, 13, 349, 10.3748/wjg.v13.i3.349 · DOI
  30. Stoicov, 2009, Green Tea Inhibits Helicobacter Growth in Vivo and in Vitro, Int. J. Antimicrob. Agents, 33, 473, 10.1016/j.ijantimicag.2008.10.032 · DOI
  31. Yee, 2000, Anti-Helicobacter Pylori Activity of Chinese Tea: In Vitro Study: Anti-H. Pylori activity of Chinese tea, Aliment. Pharmacol. Ther., 14, 635, 10.1046/j.1365-2036.2000.00747.x · DOI
  32. Raj, 2021, Epigallocatechin Gallate with Potent Anti-Helicobacter Pylori Activity Binds Efficiently to Its Histone-like DNA Binding Protein, ACS Omega, 6, 3548, 10.1021/acsomega.0c04763 · DOI
  33. Dias, 2021, Recent Advances on Dietary Polyphenol’s Potential Roles in Celiac Disease, Trends Food Sci. Technol., 107, 213, 10.1016/j.tifs.2020.10.033 · DOI
  34. Unno, 2014, Effect of Dietary Supplementation of (-Epigallocatechin Gallate on Gut Microbiota and Biomarkers of Colonic Fermentation in Rats, J. Nutr. Sci. Vitaminol, 60, 213, 10.3177/jnsv.60.213 · DOI
  35. Jin, 2012, Effects of Green Tea Consumption on Human Fecal Microbiota with Special Reference to Bifidobacterium Species: Effects of Green Tea on Fecal Microbiota, Microbiol. Immunol., 56, 729, 10.1111/j.1348-0421.2012.00502.x · DOI
  36. Barbalho, 2019, Green Tea: A Possibility in the Therapeutic Approach of Inflammatory Bowel Diseases?: Green Tea and Inflammatory Bowel Diseases, Complement. Ther. Med., 43, 148, 10.1016/j.ctim.2019.01.015 · DOI
  37. Rahman, 2018, Treatment of Inflammatory Bowel Disease via Green Tea Polyphenols: Possible Application and Protective Approaches, Inflammopharmacology, 26, 319, 10.1007/s10787-018-0462-4 · DOI
  38. Nakachi, 2000, Preventive Effects of Drinking Green Tea on Cancer and Cardiovascular Disease: Epidemiological Evidence for Multiple Targeting Prevention, Biofactors, 13, 49, 10.1002/biof.5520130109 · DOI
  39. Shimizu, 2008, Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study, Cancer Epidemiol. Biomarkers Prev., 17, 3020, 10.1158/1055-9965.EPI-08-0528 · DOI · Paper page
  40. Zhu, 2020, Tea Consumption and Colorectal Cancer Risk: A Meta-Analysis of Prospective Cohort Studies, Eur. J. Nutr., 59, 3603, 10.1007/s00394-020-02195-3 · DOI
  41. Wada, 2019, Green Tea Intake and Colorectal Cancer Risk in Japan: The Takayama Study, Jpn. J. Clin. Oncol., 49, 515, 10.1093/jjco/hyz030 · DOI
  42. Okubo, 1992, In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism, Biosci. Biotechnol. Biochem., 56, 588, 10.1271/bbb.56.588 · DOI
  43. Boyanova, 2015, Honey and Green/Black Tea Consumption May Reduce the Risk of Helicobacter Pylori Infection, Diagn. Microbiol. Infect. Dis., 82, 85, 10.1016/j.diagmicrobio.2015.03.001 · DOI
  44. Dryden, 2013, A Pilot Study to Evaluate the Safety and Efficacy of an Oral Dose of (−)-Epigallocatechin-3-Gallate–Rich Polyphenon E in Patients with Mild to Moderate Ulcerative Colitis, Inflamm. Bowel Dis., 19, 1904
  45. Xiao, 2018, A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy, Front. Pharmacol., 9, 1534, 10.3389/fphar.2018.01534 · DOI
  46. Orallo, 2006, Comparative Studies of the Antioxidant Effects of Cis-and Trans-Resveratrol, Curr. Med. Chem., 13, 87, 10.2174/092986706775197962 · DOI
  47. Berman, A.Y., Motechin, R.A., Wiesenfeld, M.Y., and Holz, M.K. (2017). The Therapeutic Potential of Resveratrol: A Review of Clinical Trials. NPJ Precis. Oncol., 1. · DOI · Paper page
  48. Chiu, 2020, The Role of Nutraceuticals as a Complementary Therapy against Various Neurodegenerative Diseases: A Mini-Review, J. Tradit. Complement. Med., 10, 434, 10.1016/j.jtcme.2020.03.008 · DOI
  49. Koushki, 2018, Resveratrol: A Miraculous Natural Compound for Diseases Treatment, Food Sci. Nutr., 6, 2473, 10.1002/fsn3.855 · DOI · Paper page
  50. Coimbra, 2011, Improving Solubility and Chemical Stability of Natural Compounds for Medicinal Use by Incorporation into Liposomes, Int. J. Pharm., 416, 433, 10.1016/j.ijpharm.2011.01.056 · DOI
  51. Walle, 2004, High Absorption but Very Low Bioavailability of Oral Resveratrol in Humans, Drug Metab. Dispos., 32, 1377, 10.1124/dmd.104.000885 · DOI · Paper page
  52. 2008, Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases, CNS Neurosci. Ther., 14, 234, 10.1111/j.1755-5949.2008.00045.x · DOI
  53. Wang, 2020, Mechanisms of Resveratrol in the Prevention and Treatment of Gastrointestinal Cancer, World J. Clin. Cases, 8, 2425, 10.12998/wjcc.v8.i12.2425 · DOI
  54. Zulueta, 2015, Resveratrol: A Potential Challenger against Gastric Cancer, World J. Gastroenterol., 21, 10636, 10.3748/wjg.v21.i37.10636 · DOI
  55. Li, 2019, Anti-Colorectal Cancer Targets of Resveratrol and Biological Molecular Mechanism: Analyses of Network Pharmacology, Human and Experimental Data, J. Cell. Biochem., 120, 11265, 10.1002/jcb.28404 · DOI
  56. Honari, 2019, Resveratrol Is a Promising Agent for Colorectal Cancer Prevention and Treatment: Focus on Molecular Mechanisms, Cancer Cell Int., 19, 180, 10.1186/s12935-019-0906-y · DOI
  57. Jing, 2016, Resveratrol Induces Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells via the PTEN Regulated PI3K/Akt Signaling Pathway, Oncol. Rep., 35, 472, 10.3892/or.2015.4384 · DOI
  58. Ji, Q., Liu, X., Han, Z., Zhou, L., Sui, H., Yan, L., Jiang, H., Ren, J., Cai, J., and Li, Q. (2015). Resveratrol Suppresses Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-Β1/Smads Signaling Pathway Mediated Snail/E-Cadherin Expression. BMC Cancer, 15. · DOI
  59. Liu, 2014, The PTEN/PI3K/Akt and Wnt/β-Catenin Signaling Pathways Are Involved in the Inhibitory Effect of Resveratrol on Human Colon Cancer Cell Proliferation, Int. J. Oncol., 45, 104, 10.3892/ijo.2014.2392 · DOI
  60. Soleimani, 2020, Role of the NF-ΚB Signaling Pathway in the Pathogenesis of Colorectal Cancer, Gene, 726, 144132, 10.1016/j.gene.2019.144132 · DOI
  61. Paulo, 2011, Anti-Helicobacter Pylori and Urease Inhibitory Activities of Resveratrol and Red Wine, Food Res. Int., 44, 964, 10.1016/j.foodres.2011.02.017 · DOI
  62. Mahady, 2003, Resveratrol and Red Wine Extracts Inhibit the Growth of CagA+ Strains of Helicobacter Pylori in Vitro, Am. J. Gastroenterol., 98, 1440, 10.1111/j.1572-0241.2003.07513.x · DOI
  63. Xia, 2020, The Synergy of Resveratrol and Alcohol against Helicobacter Pylori and Underlying Anti-Helicobacter Pylori Mechanism of Resveratrol, J. Appl. Microbiol., 128, 1179, 10.1111/jam.14531 · DOI
  64. Zhang, 2015, Resveratrol Protects against Helicobacter Pylori-Associated Gastritis by Combating Oxidative Stress, Int. J. Mol. Sci., 16, 27757, 10.3390/ijms161126061 · DOI
  65. Hu, 2019, The Bidirectional Interactions between Resveratrol and Gut Microbiota: An Insight into Oxidative Stress and Inflammatory Bowel Disease Therapy, Biomed Res. Int., 2019, 5403761, 10.1155/2019/5403761 · DOI
  66. Alrafas, 2019, Resveratrol Modulates the Gut Microbiota to Prevent Murine Colitis Development through Induction of Tregs and Suppression of Th17 Cells, J. Leukoc. Biol., 106, 467, 10.1002/JLB.3A1218-476RR · DOI
  67. Nunes, 2018, Resveratrol and Inflammatory Bowel Disease: The Evidence so Far, Nutr. Res. Rev., 31, 85, 10.1017/S095442241700021X · DOI
  68. Singh, 2019, Health Benefits of Resveratrol: Evidence from Clinical Studies: SINGH et Al, Med. Res. Rev., 39, 1851, 10.1002/med.21565 · DOI · Paper page
  69. Carroll, 2011, Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia, Cancer Prev. Res., 4, 354, 10.1158/1940-6207.CAPR-10-0098 · DOI · Paper page
  70. Patel, 2010, Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients, Cancer Res., 70, 7392, 10.1158/0008-5472.CAN-10-2027 · DOI
  71. Choudhari, 2020, Corrigendum: Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice, Front. Pharmacol., 11, 175, 10.3389/fphar.2020.00175 · DOI
  72. Patra, S., Pradhan, B., Nayak, R., Behera, C., Rout, L., Jena, M., Efferth, T., and Bhutia, S.K. (2020). Chemotherapeutic Efficacy of Curcumin and Resveratrol against Cancer: Chemoprevention, Chemoprotection, Drug Synergism and Clinical Pharmacokinetics. Semin. Cancer Biol. · DOI
  73. Cardona, 2016, Red Wine Polyphenols Modulate Fecal Microbiota and Reduce Markers of the Metabolic Syndrome in Obese Patients, Food Funct., 7, 1775, 10.1039/C5FO00886G · DOI · Paper page
  74. Samsamikor, 2016, Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study, Arch. Med. Res., 47, 304, 10.1016/j.arcmed.2016.07.003 · DOI
  75. Samsamikor, 2015, Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study, Arch. Med. Res., 46, 280, 10.1016/j.arcmed.2015.05.005 · DOI
  76. Venkatakrishnan, 2019, Extensive Review of Popular Functional Foods and Nutraceuticals against Obesity and Its Related Complications with a Special Focus on Randomized Clinical Trials, Food Funct., 10, 2313, 10.1039/C9FO00293F · DOI
  77. Mantzorou, 2018, Effects of Curcumin Consumption on Human Chronic Diseases: A Narrative Review of the Most Recent Clinical Data, Phytother. Res., 32, 957, 10.1002/ptr.6037 · DOI
  78. Sadeghi, 2020, The Effect of Curcumin Supplementation on Clinical Outcomes and Inflammatory Markers in Patients with Ulcerative Colitis, Phytother. Res., 34, 1123, 10.1002/ptr.6581 · DOI · Paper page
  79. Hasan, 2014, Liposome Encapsulation of Curcumin: Physico-Chemical Characterizations and Effects on MCF7 Cancer Cell Proliferation, Int. J. Pharm., 461, 519, 10.1016/j.ijpharm.2013.12.007 · DOI
  80. Sharma, 2012, Curcumin Heals Indomethacin-Induced Gastric Ulceration by Stimulation of Angiogenesis and Restitution of Collagen Fibers via VEGF and MMP-2 Mediated Signaling, Antioxid. Redox Signal., 16, 351, 10.1089/ars.2011.4232 · DOI
  81. Kunnumakkara, 2008, Curcumin Inhibits Proliferation, Invasion, Angiogenesis and Metastasis of Different Cancers through Interaction with Multiple Cell Signaling Proteins, Cancer Lett., 269, 199, 10.1016/j.canlet.2008.03.009 · DOI · Paper page
  82. Li, 2017, Curcumin Induces Apoptotic Cell Death and Protective Autophagy in Human Gastric Cancer Cells, Oncol. Rep., 37, 3459, 10.3892/or.2017.5637 · DOI
  83. Mosieniak, 2012, Curcumin Induces Permanent Growth Arrest of Human Colon Cancer Cells: Link between Senescence and Autophagy, Mech. Ageing Dev., 133, 444, 10.1016/j.mad.2012.05.004 · DOI
  84. McFadden, 2015, The Role of Curcumin in Modulating Colonic Microbiota during Colitis and Colon Cancer Prevention, Inflamm. Bowel Dis., 21, 2483, 10.1097/MIB.0000000000000522 · DOI
  85. Haghi, 2017, A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer, J. Gastrointest. Cancer, 48, 314, 10.1007/s12029-017-9997-7 · DOI
  86. Kundu, P., De, R., Pal, I., Mukhopadhyay, A.K., Saha, D.R., and Swarnakar, S. (2011). Curcumin Alleviates Matrix Metalloproteinase-3 and-9 Activities during Eradication of Helicobacter Pylori Infection in Cultured Cells and Mice. PLoS ONE, 6. · DOI
  87. Garcea, 2005, Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and Their Pharmacodynamic Consequences, Cancer Epidemiol. Biomarkers Prev., 14, 120, 10.1158/1055-9965.120.14.1 · DOI · Paper page
  88. Adiwidjaja, 2017, Curcumin as a Clinically-Promising Anti-Cancer Agent: Pharmacokinetics and Drug Interactions, Expert Opin. Drug Metab. Toxicol., 13, 953, 10.1080/17425255.2017.1360279 · DOI
  89. Hanai, 2006, Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial, Clin. Gastroenterol. Hepatol., 4, 1502, 10.1016/j.cgh.2006.08.008 · DOI · Paper page
  90. Koosirirat, 2010, Investigation of the Anti-Inflammatory Effect of Curcuma Longa in Helicobacter Pylori-Infected Patients, Int. Immunopharmacol., 10, 815, 10.1016/j.intimp.2010.04.021 · DOI · Paper page
  91. Cavallaro, 2007, A Curcumin-Based 1-Week Triple Therapy for Eradication of Helicobacter Pylori Infection: Something to Learn from Failure?, Helicobacter, 12, 238, 10.1111/j.1523-5378.2007.00497.x · DOI
  92. Davoodvandi, 2020, Quercetin as an Anticancer Agent: Focus on Esophageal Cancer, J. Food Biochem., 44, e13374, 10.1111/jfbc.13374 · DOI
  93. Maalik, 2014, Pharmacological Applications of Quercetin and Its Derivatives: A Short Review, Trop. J. Pharm. Res., 13, 1561, 10.4314/tjpr.v13i9.26 · DOI
  94. Lu, 2015, Hypocholesterolemic Efficacy of Quercetin Rich Onion Juice in Healthy Mild Hypercholesterolemic Adults: A Pilot Study, Plant Foods Hum. Nutr., 70, 395, 10.1007/s11130-015-0507-4 · DOI
  95. Santangelo, 2019, Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions, Food Chem Toxicol., 123, 42, 10.1016/j.fct.2018.10.042 · DOI
  96. Castillo, 2016, Molecular Mechanisms of Gastrointestinal Protection by Quercetin against Indomethacin-Induced Damage: Role of NF-ΚB and Nrf2, J. Nutr. Biochem., 27, 289, 10.1016/j.jnutbio.2015.09.016 · DOI
  97. Darband, 2018, Quercetin: A Functional Dietary Flavonoid with Potential Chemo-Preventive Properties in Colorectal Cancer, J. Cell. Physiol., 233, 6544, 10.1002/jcp.26595 · DOI
  98. Choi, 2003, Anti-and Prooxidant Effects of Chronic Quercetin Administration in Rats, Eur. J. Pharmacol., 482, 281, 10.1016/j.ejphar.2003.09.067 · DOI
  99. Shang, 2018, Quercetin Induced Cell Apoptosis and Altered Gene Expression in AGS Human Gastric Cancer Cells, Environ. Toxicol., 33, 1168, 10.1002/tox.22623 · DOI
  100. Kim, 2010, Apoptotic Effect of Quercetin on HT-29 Colon Cancer Cells via the AMPK Signaling Pathway, J. Agric. Food Chem., 58, 8643, 10.1021/jf101510z · DOI
  101. Rauf, 2018, Anticancer Potential of Quercetin: A Comprehensive Review: Quercetin as an Anticancer Agent, Phytother. Res., 32, 2109, 10.1002/ptr.6155 · DOI
  102. Shan, 2009, Quercetin Inhibit Human SW480 Colon Cancer Growth in Association with Inhibition of Cyclin D1 and Survivin Expression through Wnt/β-Catenin Signaling Pathway, Cancer Investig., 27, 604, 10.1080/07357900802337191 · DOI
  103. Lambert, 2010, The Antioxidant and Pro-Oxidant Activities of Green Tea Polyphenols: A Role in Cancer Prevention, Arch. Biochem. Biophys., 501, 65, 10.1016/j.abb.2010.06.013 · DOI
  104. Pang, 2019, Prediction of New Targets and Mechanisms for Quercetin in the Treatment of Pancreatic Cancer, Colon Cancer, and Rectal Cancer, Food Funct., 10, 5339, 10.1039/C9FO01168D · DOI
  105. Amasheh, 2008, Quercetin Enhances Epithelial Barrier Function and Increases Claudin-4 Expression in Caco-2 Cells, J. Nutr., 138, 1067, 10.1093/jn/138.6.1067 · DOI
  106. Zhang, 2017, Quercetin from Polygonum Capitatum Protects against Gastric Inflammation and Apoptosis Associated with Helicobacter Pylori Infection by Affecting the Levels of P38MAPK, BCL-2 and BAX, Molecules, 22, 744, 10.3390/molecules22050744 · DOI
  107. Porras, 2017, Protective Effect of Quercetin on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice Is Mediated by Modulating Intestinal Microbiota Imbalance and Related Gut-Liver Axis Activation, Free Radic. Biol. Med., 102, 188, 10.1016/j.freeradbiomed.2016.11.037 · DOI
  108. Askari, 2012, The Effect of Quercetin Supplementation on Selected Markers of Inflammation and Oxidative Stress, J. Res. Med. Sci., 17, 637
  109. Serafini, 2011, Dietary Quercetin Intake and Risk of Gastric Cancer: Results from a Population-Based Study in Sweden, Ann. Oncol., 22, 438, 10.1093/annonc/mdq390 · DOI
  110. Li, 2020, Synergic Interactions between Polyphenols and Gut Microbiota in Mitigating Inflammatory Bowel Diseases, Food Funct., 11, 4878, 10.1039/D0FO00713G · DOI
  111. Roudsari, 2019, Natural Polyphenols for the Prevention of Irritable Bowel Syndrome: Molecular Mechanisms and Targets; a Comprehensive Review, Daru, 27, 755, 10.1007/s40199-019-00284-1 · DOI
  112. Kaulmann, 2016, Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls, Oxid. Med. Cell. Longev., 2016, 9346470, 10.1155/2016/9346470 · DOI
  113. Pei, 2020, Flavonoids and Gut Health, Curr. Opin. Biotechnol., 61, 153, 10.1016/j.copbio.2019.12.018 · DOI
  114. Adhami, 2007, Combined Inhibitory Effects of Green Tea Polyphenols and Selective Cyclooxygenase-2 Inhibitors on the Growth of Human Prostate Cancer Cells Both in Vitro and in Vivo, Clin. Cancer Res., 13, 1611, 10.1158/1078-0432.CCR-06-2269 · DOI
  115. Suganuma, 1999, Synergistic Effects of (−)-Epigallocatechin Gallate with (−)-Epicatechin, Sulindac, or Tamoxifen on Cancer-Preventive Activity in the Human Lung Cancer cell Line PC-9, Cancer Res., 59, 44

Cited by

Metadata

Authors
Chiu, H.-F., Venkatakrishnan, K., Golovinskaia, O., & Wang, C.-K.
Venue
Molecules
Publisher
MDPI AG
Published
2021-04-06
Volume
26
Issue
7
Pages
2090
ISSN
1420-3049
DOI
10.3390/molecules26072090
Cited by
101
References
11
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.